Kurz, S. C., Zan, E., Peereboom, D. M., Cordova, C., Sulman, E. P., Lobbous, M., Barbaro, M., Malkin, M. G., Miller, A. M., Dhawan, A., Torres-trejo, A., Stevens, G., Silverman, J. S., Snuderl, M., Zagzag, D., Golfinos, J. G., Kondziolka, D., Troxel, A., Friedman, K. P., Shepherd, T. (2026). Final results of a single-arm, open-label, multicenter phase 2 study of the radiopharmaceutical [
                    <sup>177</sup>
                    Lu]Lu-DOTA-TATE and [
                    <sup>68</sup>
                    Ga]Ga-DOTA-TATE in adults with advanced intracranial meningioma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2090